Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("SWAIN, Sandra M")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 64

  • Page / 3

Export

Selection :

  • and

Inflammatory breast cancerSWAIN, Sandra M.Breast disease. 2005, Vol 22, issn 0888-6008, 83 p.Serial Issue

Clinical aspects of inflammatory breast cancerWALSHE, Janice M; SWAIN, Sandra M.Breast disease. 2005, Vol 22, pp 35-44, issn 0888-6008, 10 p.Article

Primary Systemic Chemotherapy for Inflammatory Breast CancerSINCLAIR, Sarah; SWAIN, Sandra M.Cancer. 2010, Vol 116, Num 11, pp 2821-2828, issn 0008-543X, 8 p., SUPConference Paper

Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancerWALSHE, Janice M; DENDULURI, Neelima; SWAIN, Sandra M et al.Journal of clinical oncology. 2006, Vol 24, Num 36, pp 5769-5779, issn 0732-183X, 11 p.Article

Cardiac Toxicity in Breast Cancer Survivors : Review of Potential Cardiac ProblemsHEALEY BIRD, Brian R. J; SWAIN, Sandra M.Clinical cancer research. 2008, Vol 14, Num 1, pp 14-24, issn 1078-0432, 11 p.Article

Imaging in inflammatory breast carcinomaCHOW, Catherine K.Breast disease. 2005, Vol 22, pp 45-54, issn 0888-6008, 10 p.Article

Ductal carcinoma in situ, complexities and challengesLEONARD, Gregory D; SWAIN, Sandra M.Journal of the National Cancer Institute. 2004, Vol 96, Num 12, pp 906-920, issn 0027-8874, 15 p.Article

Adjuvant chemotherapy for breast cancer: an updateTAN, Antoinette R; SWAIN, Sandra M.Seminars in oncology. 2001, Vol 28, Num 4, pp 359-376, issn 0093-7754Article

Molecular biology of inflammatory breast cancer: Applications to diagnosis, prognosis, and therapyMEI WU; MERAJVER, Sofia D.Breast disease. 2005, Vol 22, pp 25-34, issn 0888-6008, 10 p.Article

The Epothilones : Translating from the Laboratory to the Clinic : The development of new cytotoxic agents in clinical oncologyLEE, James J; SWAIN, Sandra M.Clinical cancer research. 2008, Vol 14, Num 6, pp 1618-1624, issn 1078-0432, 7 p.Article

Peripheral neuropathy induced by microtubule-stabilizing agentsLEE, James J; SWAIN, Sandra M.Journal of clinical oncology. 2006, Vol 24, Num 10, pp 1633-1642, issn 0732-183X, 10 p.Article

Systemic treatments for inflammatory breast cancerYANG, Charles H; CRISTOFANILLI, Massimo.Breast disease. 2005, Vol 22, pp 55-65, issn 0888-6008, 11 p.Article

Surgical aspects of inflammatory breast cancerKELL, Malcolm R; MORROW, Monica.Breast disease. 2005, Vol 22, pp 67-73, issn 0888-6008, 7 p.Article

Tamoxifen for patients with estrogen receptor-negative breast cancerSWAIN, Sandra M.Journal of clinical oncology. 2001, Vol 19, Num 18, pp 93s-97s, issn 0732-183X, SUPConference Paper

Inflammatory breast cancer: Current concepts in local managementBRISTOL, Ian J; BUCHHOLZ, Thomas A.Breast disease. 2005, Vol 22, pp 75-83, issn 0888-6008, 9 p.Article

Ongoing adjuvant trials with trastuzumab in breast cancerTAN, Antoinette R; SWAIN, Sandra M.Seminars in oncology. 2003, Vol 30, Num 5, pp 54-64, issn 0093-7754, 11 p., SUP16Conference Paper

Congestive heart failure in patients treated with doxorubicin: A retrospective analysis of three trialsSWAIN, Sandra M; WHALEY, Fredrick S; EWER, Michael S et al.Cancer. 2003, Vol 97, Num 11, pp 2869-2879, issn 0008-543X, 11 p.Article

Review of flavopiridol, a cyclin-dependent kinase inhibitor, as breast cancer therapyTAN, Antoinette R; SWAIN, Sandra M.Seminars in oncology. 2002, Vol 29, Num 3, pp 77-85, issn 0093-7754, SUP11Article

Development of novel chemotherapeutic agents to evade the mechanisms of multidrug resistance (MDR)LEE, James J; SWAIN, Sandra M.Seminars in oncology. 2005, Vol 32, Num 6, pp S22-S26, issn 0093-7754, SUP7Article

Novel agents: Clinical trial designTAN, Antoinette R; SWAIN, Sandra M.Seminars in oncology. 2001, Vol 28, Num 5, pp 148-153, issn 0093-7754, SUP16Conference Paper

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysisCORTAZAR, Patricia; LIJUN ZHANG; SWAIN, Sandra M et al.Lancet (British edition). 2014, Vol 384, Num 9938, pp 164-172, issn 0140-6736, 9 p.Article

Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)MILES, David; BASELGA, José; AMADORI, Dino et al.Breast cancer research and treatment. 2013, Vol 142, Num 1, pp 89-99, issn 0167-6806, 11 p.Article

Phase I trial of the cyclin-dependent kinase inhibitor flavopiridol in combination with Docetaxel in patients with metastatic breast cancerTAN, Antoinette R; XIAOWEI YANG; SWAIN, Sandra M et al.Clinical cancer research. 2004, Vol 10, Num 15, pp 5038-5047, issn 1078-0432, 10 p.Article

Locally Advanced and Inflammatory Breast CancerCHIA, Stephen; SWAIN, Sandra M; BYRD, David R et al.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 786-790, issn 0732-183X, 5 p.Article

Epidemiology of Inflammatory Breast Cancer (IBC)ANDERSON, William F; SCHAIRER, Catherine; CHEN, Bingshu E et al.Breast disease. 2005, Vol 22, pp 9-23, issn 0888-6008, 15 p.Article

  • Page / 3